Literature DB >> 12483266

Hepatobiliary transport of bile acids and organic anions.

Hajime Takikawa1.   

Abstract

Recent studies have elucidated the mechanism and regulation of hepatic transport of bile acids and organic anions. Bile acids are taken up into hepatocytes by basolateral transporters, Na+-dependently by Na+/taurocholate cotransporting polypeptide (NTCP) and Na+-independently by organic anion transporting polypeptide (OATP) families. Organic anions are taken up into hepatocytes by OATP families. These compounds are then transported in hepatocytes bound to cytosolic binders, and subjected to transport by ATP binding cassette (ABC) transporters at the canalicular membrane. Amidated bile acids are excreted into bile by bile salt export pump (BSEP), and organic anions and bile acid sulfates and glucuronides are excreted by multidrug resistance protein 2 (MRP2). Hepatic transporters are downregulated under cholestasis in rats and humans, except for MRP3, a basolateral ABC transporter, which is upregulated and may have a role in removing bile acids and organic anions from hepatocytes to the blood under cholestatic conditions. Nuclear receptors, which bind bile acids, have been shown to regulate the expression of hepatic transporters. Farnesoid X receptor (FXR), which downregulates CYP7A1, the rate-limiting enzyme of bile acid biosynthesis, upregulates BSEP and downregulates NTCP. MRP2 is upregulated by both FXR and pregnane X receptor (PXR), which upregulates CYP3A.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483266     DOI: 10.1007/s005340200055

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  13 in total

1.  Cysteine 96 of Ntcp is responsible for NO-mediated inhibition of taurocholate uptake.

Authors:  Umadevi Ramasamy; M Sawkat Anwer; Christopher M Schonhoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

2.  Nitric oxide-mediated inhibition of taurocholate uptake involves S-nitrosylation of NTCP.

Authors:  Christopher M Schonhoff; Umadevi Ramasamy; M Sawkat Anwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-25       Impact factor: 4.052

Review 3.  Bile acid detergency: permeability, inflammation, and effects of sulfation.

Authors:  Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-03-08       Impact factor: 4.052

4.  ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling.

Authors:  Yuji Tanaka; Lauren M Aleksunes; Yue Julia Cui; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2009-01-29       Impact factor: 4.849

Review 5.  Does abnormal bile acid metabolism contribute to NEC?

Authors:  Melissa D Halpern; Bohuslav Dvorak
Journal:  Semin Perinatol       Date:  2008-04       Impact factor: 3.300

6.  Localization of multidrug resistance-associated protein 2 in the nonpigmented ciliary epithelium of the eye.

Authors:  Ryan M Pelis; Mohammad Shahidullah; Sikha Ghosh; Miguel Coca-Prados; Stephen H Wright; Nicholas A Delamere
Journal:  J Pharmacol Exp Ther       Date:  2009-02-06       Impact factor: 4.030

7.  Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.

Authors:  Hiroyuki Sasabe; Yoshihiko Shimokawa; Masakazu Shibata; Kenta Hashizume; Yusuke Hamasako; Yoshihiro Ohzone; Eiji Kashiyama; Ken Umehara
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

8.  The hepatic bile acid transporters Ntcp and Mrp2 are downregulated in experimental necrotizing enterocolitis.

Authors:  Nathan J Cherrington; Teresa E Estrada; Harrison A Frisk; Mark J Canet; Rhiannon N Hardwick; Bohuslav Dvorak; Katie Lux; Melissa D Halpern
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-01       Impact factor: 4.052

9.  Yinzhihuang attenuates ANIT-induced intrahepatic cholestasis in rats through upregulation of Mrp2 and Bsep expressions.

Authors:  Qiao-Qun Ou; Xin-Hua Qian; Ding-You Li; You-Xiang Zhang; Xia-Nan Pei; Jin-Wen Chen; Li Yu
Journal:  Pediatr Res       Date:  2015-12-08       Impact factor: 3.756

Review 10.  Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges.

Authors:  Charles Awortwe; P S Fasinu; B Rosenkranz
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.